Optimized Photoactivatable Lipid Nanoparticles Enable Red Light Triggered Drug Release.

cancer doxorubicin liposome photoswitch triggered drug release

Journal

Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338

Informations de publication

Date de publication:
05 2021
Historique:
revised: 25 02 2021
received: 30 12 2020
pubmed: 22 4 2021
medline: 15 7 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

Encapsulation of small molecule drugs in long-circulating lipid nanoparticles (LNPs) can reduce toxic side effects and enhance accumulation at tumor sites. A fundamental problem, however, is the slow release of encapsulated drugs from these liposomal systems at the disease site resulting in limited therapeutic benefit. Methods to trigger release at specific sites are highly warranted. Here, it is demonstrated that incorporation of ultraviolet (UV-A) or red-light photoswitchable-phosphatidylcholine analogs (AzoPC and redAzoPC) in conventional LNPs generates photoactivatable LNPs (paLNPs) having comparable structural integrity, drug loading capacity, and size distribution to the parent DSPC-cholesterol liposomes. It is shown that 65-70% drug release (doxorubicin) can be induced from these systems by irradiation with pulsed light based on trans-to-cis azobenzene isomerization. In vitro it is confirmed that paLNPs are non-toxic in the dark but convey cytotoxicity upon irradiation in a human cancer cell line. In vivo studies in zebrafish embryos demonstrate prolonged blood circulation and extravasation of paLNPs comparable to clinically approved formulations, with enhanced drug release following irradiation with pulsed light. Conclusively, paLNPs closely mimic the properties of clinically approved LNPs with the added benefit of light-induced drug release making them promising candidates for clinical development.

Identifiants

pubmed: 33880882
doi: 10.1002/smll.202008198
doi:

Substances chimiques

Liposomes 0
Doxorubicin 80168379AG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2008198

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

T. M. Allen, P. R. Cullis, Adv. Drug Delivery Rev. 2013, 65, 36.
A. Wicki, D. Witzigmann, V. Balasubramanian, J. Huwyler, J. Controlled Release 2015, 200, 138.
J. Buck, P. Grossen, P. R. Cullis, J. Huwyler, D. Witzigmann, ACS Nano 2019, 13, 3754.
G. Bozzuto, A. Molinari, Int. J. Nanomed. 2015, 10, 975.
J. A. Kulkarni, D. Witzigmann, S. Chen, P. R. Cullis, R. van der Meel, Acc. Chem. Res. 2019, 52, 2435.
A. Akinc, M. A. Maier, M. Manoharan, K. Fitzgerald, M. Jayaraman, S. Barros, S. Ansell, X. Du, M. J. Hope, T. D. Madden, Nat. Nanotechnol. 2019, 14, 1084.
A. Gabizon, R. Catane, B. Uziely, B. Kaufman, T. Safra, R. Cohen, F. Martin, A. Huang, Y. Barenholz, Cancer Res. 1994, 54, 987.
R. T. Chlebowski, West. J. Med. 1979, 131, 364.
D. Bobo, K. J. Robinson, J. Islam, K. J. Thurecht, S. R. Corrie, Pharm. Res. 2016, 33, 2373.
D. Papahadjopoulos, T. M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S. K. Huang, K. D. Lee, M. C. Woodle, D. D. Lasic, C. Redemann, Proc. Natl. Acad. Sci. USA 1991, 88, 11460.
A. Gabizon, H. Shmeeda, Y. Barenholz, Clin. Pharmacokinet. 2003, 42, 419.
L. D. Mayer, L. C. Tai, D. S. Ko, D. Masin, R. S. Ginsberg, P. R. Cullis, M. B. Bally, Cancer Res. 1989, 49, 5922.
S. Bibi, E. Lattmann, A. R. Mohammed, Y. Perrie, J. Microencapsulation 2012, 29, 262.
A. Dabbagh, B. J. J. Abdullah, H. Abdullah, M. Hamdi, N. H. A. Kasim, J. Pharm. Sci. 2015, 104, 2414.
M. E. Lorkowski, P. U. Atukorale, K. B. Ghaghada, E. Karathanasis, Adv. Healthcare Mater. 2020, 10, e2001044.
N. Forbes, A. Pallaoro, N. O. Reich, J. A. Zasadzinski, Part. Part. Syst. Charact. 2014, 31, 1158.
D. Needham, G. Anyarambhatla, G. Kong, M. W. Dewhirst, Cancer Res. 2000, 60, 1197.
U. Bulbake, S. Doppalapudi, N. Kommineni, W. Khan, Pharmaceutics 2017, 9, 12.
C. D. Landon, J.-Y. Park, D. Needham, M. W. Dewhirst, Open Nanomed. J. 2011, 3, 24.
Y. Dou, K. Hynynen, C. Allen, J. Controlled Release 2017, 249, 63.
Celsion, A Phase III, Randomized, Double Blind, Clinicaltrials.Gov 2018.
C. Pernpeintner, J. A. Frank, P. Urban, C. R. Roeske, S. D. Pritzl, D. Trauner, T. Lohmüller, Langmuir 2017, 33, 4083.
K. Hüll, J. Morstein, D. Trauner, Chem. Rev. 2018, 118, 10710.
D. Miranda, J. F. Lovell, Bioeng. Transl. Med. 2016, 1, 267.
R. H. Bisby, C. Mead, C. G. Morgan, Photochem. Photobiol. 2000, 72, 57.
D. Luo, K. A. Carter, A. Razi, J. Geng, S. Shao, D. Giraldo, U. Sunar, J. Ortega, J. F. Lovell, Biomaterials 2016, 75, 193.
K. A. Carter, D. Luo, J. Geng, S. T. Stern, J. F. Lovell, Mol. Cancer Ther. 2019, 18, 592.
J. Morstein, A. C. Impastato, D. Trauner, ChemBioChem 2021, 22, 73.
D. B. Konrad, J. A. Frank, D. Trauner, Chem. Eur. J. 2016, 22, 4364.
M. M. Lerch, M. J. Hansen, G. M. van Dam, W. Szymanski, B. L. Feringa, Angew. Chem., Int. Ed. 2016, 55, 10978.
R. Pattipeiluhu, S. Crielaard, I. Klein-Schiphorst, B. I. Florea, A. Kros, F. Campbell, ACS Cent. Sci. 2020, 6, 535.
G. Caracciolo, Nanoscale 2018, 10, 4167.
Y. Barenholz, J. Controlled Release 2012, 160, 117.
S. Bleher, J. Buck, C. Muhl, S. Sieber, S. Barnert, D. Witzigmann, J. Huwyler, M. Barz, R. Süss, Small 2019, 15, 1904716.
S. Sieber, P. Grossen, J. Bussmann, F. Campbell, A. Kros, D. Witzigmann, J. Huwyler, Adv. Drug Delivery Rev. 2019, 151-152, 152.
S. H. Yun, S. J. J. Kwok, Nat. Biomed. Eng. 2017, 1, 0008.
J. Morstein, D. Trauner, Curr. Opin. Chem. Biol. 2019, 50, 145.
M. Borowiak, W. Nahaboo, M. Reynders, K. Nekolla, P. Jalinot, J. Hasserodt, M. Rehberg, M. Delattre, S. Zahler, A. Vollmar, Cell 2015, 162, 403.
D. Witzigmann, S. Sieber, F. Porta, P. Grossen, A. Bieri, N. Strelnikova, T. Pfohl, C. Prescianotto-Baschong, J. Huwyler, RSC Adv. 2015, 5, 74320.
S. Sieber, P. Grossen, P. Detampel, S. Siegfried, D. Witzigmann, J. Huwyler, J. Controlled Release 2017, 264, 180.
J. A. Kulkarni, D. Witzigmann, J. Leung, R. van der Meel, J. Zaifman, M. M. Darjuan, H. M. Grisch-Chan, B. Thöny, Y. Y. C. Tam, P. R. Cullis, Nanoscale 2019, 11, 9023.
D. Witzigmann, P. Uhl, S. Sieber, C. Kaufman, T. Einfalt, K. Schöneweis, P. Grossen, J. Buck, Y. Ni, S. H. Schenk, eLife 2019, 8, e42276.

Auteurs

Nisha Chander (N)

Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada.

Johannes Morstein (J)

Department of Chemistry, New York University, 100 Washington Square East, Room 712, New York, NY, 10003, USA.

Jan S Bolten (JS)

Department of Pharmaceutical Technology, University of Basel, Klingelbergstrasse 50, Basel, 4056, Switzerland.

Andrej Shemet (A)

Department of Chemistry, New York University, 100 Washington Square East, Room 712, New York, NY, 10003, USA.

Pieter R Cullis (PR)

Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada.
NanoMedicines Innovation Network (NMIN), University of British Columbia, 2350 Health Sciences Mall, Room 5451, Vancouver, BC, V6T 1Z3, Canada.

Dirk Trauner (D)

Department of Chemistry, New York University, 100 Washington Square East, Room 712, New York, NY, 10003, USA.

Dominik Witzigmann (D)

Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada.
NanoMedicines Innovation Network (NMIN), University of British Columbia, 2350 Health Sciences Mall, Room 5451, Vancouver, BC, V6T 1Z3, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH